Cambridge Investment Research Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$365K Sell
5,653
-1,763
-24% -$124K ﹤0.01% 3098
2025
Q4
$499K Buy
7,416
+366
+5% +$24.6K ﹤0.01% 2719
2025
Q3
$517K Buy
7,050
+43
+0.6% +$2.86K ﹤0.01% 2649
2025
Q2
$365K Buy
7,007
+131
+2% +$7.45K ﹤0.01% 2817
2025
Q1
$439K Sell
6,876
-155
-2% -$9K ﹤0.01% 2556
2024
Q4
$336K Sell
7,031
-2,530
-26% -$130K ﹤0.01% 2750
2024
Q3
$547K Buy
9,561
+2,547
+36% +$146K ﹤0.01% 2335
2024
Q2
$367K Sell
7,014
-354
-5% -$15.5K ﹤0.01% 2550
2024
Q1
$300K Sell
7,368
-698
-9% -$26.2K ﹤0.01% 2703
2023
Q4
$298K Buy
8,066
+832
+12% +$31.3K ﹤0.01% 2600
2023
Q3
$276K Buy
7,234
+16
+0.2% +$655 ﹤0.01% 2557
2023
Q2
$260K Sell
7,218
-901
-11% -$30.7K ﹤0.01% 2662
2023
Q1
$310K Sell
8,119
-356
-4% -$16.7K ﹤0.01% 2461
2022
Q4
$482K Sell
8,475
-505
-6% -$25.9K ﹤0.01% 2042
2022
Q3
$355K Buy
8,980
+1,218
+16% +$53.8K ﹤0.01% 2233
2022
Q2
$342K Buy
7,762
+200
+3% +$8.65K ﹤0.01% 2264
2022
Q1
$302K Sell
7,562
-372
-5% -$13.3K ﹤0.01% 2549
2021
Q4
$319K Buy
7,934
+1,128
+17% +$42.1K ﹤0.01% 2476
2021
Q3
$277K Buy
6,806
+1,588
+30% +$66.4K ﹤0.01% 2527
2021
Q2
$237K Sell
5,218
-939
-15% -$41.6K ﹤0.01% 2672
2021
Q1
$257K Buy
6,157
+23
+0.4% +$1.05K ﹤0.01% 2404
2020
Q4
$262K Buy
+6,134
New +$220K ﹤0.01% 2255
2020
Q3
Sell
-9,435
Closed -$253K 2557
2020
Q2
$253K Buy
+9,435
New +$213K ﹤0.01% 2021
2020
Q1
Sell
-10,483
Closed -$186K 2358
2019
Q4
$186K Sell
10,483
-99
-0.9% -$1.72K ﹤0.01% 2236
2019
Q3
$164K Sell
10,582
-600
-5% -$9.88K ﹤0.01% 2162
2019
Q2
$192K Sell
11,182
-500
-4% -$8.07K ﹤0.01% 2008
2019
Q1
$188K Buy
11,682
+382
+3% +$6.19K ﹤0.01% 2085
2018
Q4
$165K Hold
11,300
﹤0.01% 1967
2018
Q3
$205K Buy
+11,300
New +$198K ﹤0.01% 2042

Other funds holding HALO